Portal de Periódicos da CAPES

The role of liquid chromatography–tandem mass spectrometry in the clinical laboratory

2011; Elsevier BV; Volume: 883-884; Linguagem: Inglês

10.1016/j.jchromb.2011.11.044

1873-376X

Johannes M.W. van den Ouweland, Ido P. Kema,

Metabolomics and Mass Spectrometry Studies

Liquid chromatography coupled to mass spectrometry (LC–MS/MS) is increasingly used as a routine methodology in clinical laboratories for the analysis of low molecular weight molecules. The high specificity in combination with high sensitivity and multi-analyte potential makes it an attractive complementary method to traditional methodology used for routine applications. Its strength and weaknesses in this context will be discussed and examples of successful clinical applications will be given. For LC–MS/MS to truly fulfil its promise in clinical diagnosis, the prerequisite steps being sample pre-treatment, chromatographic separation and detection by selected reaction monitoring must become more integrated as they are in conventional clinical analysers. The availability of ready-to-use reagents kits, eliminating efforts needed for method development and extensive validation, are likely to contribute to a wider acceptance of LC–MS/MS in clinical laboratories. Growing applicability of LC–MS/MS in the clinical laboratory field is expected from quantitative protein analysis.